-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
ISpecimen Inc. (NASDAQ:ISPC) Short Interest Update
ISpecimen Inc. (NASDAQ:ISPC) Short Interest Update
iSpecimen Inc. (NASDAQ:ISPC – Get Rating) was the recipient of a large increase in short interest in December. As of December 30th, there was short interest totalling 165,800 shares, an increase of 11.1% from the December 15th total of 149,300 shares. Based on an average daily trading volume, of 25,400 shares, the days-to-cover ratio is currently 6.5 days. Approximately 3.5% of the shares of the company are sold short.
iSpecimen Stock Performance
Shares of NASDAQ:ISPC remained flat at $1.63 during trading on Friday. The stock had a trading volume of 12,701 shares, compared to its average volume of 19,421. The business's 50 day moving average price is $1.47 and its 200 day moving average price is $1.84. The company has a debt-to-equity ratio of 0.12, a quick ratio of 8.55 and a current ratio of 8.55. iSpecimen has a 1 year low of $1.17 and a 1 year high of $5.70.
Get iSpecimen alerts:iSpecimen (NASDAQ:ISPC – Get Rating) last released its earnings results on Tuesday, November 8th. The company reported ($0.35) earnings per share for the quarter. iSpecimen had a negative net margin of 101.49% and a negative return on equity of 38.56%. The company had revenue of $2.58 million for the quarter.
Analysts Set New Price Targets
Separately, Craig Hallum cut their target price on iSpecimen to $11.00 in a research report on Tuesday, November 15th.Institutional Trading of iSpecimen
Several institutional investors and hedge funds have recently modified their holdings of ISPC. Jane Street Group LLC bought a new stake in shares of iSpecimen during the 1st quarter worth $56,000. Grimes & Company Inc. lifted its position in shares of iSpecimen by 78.3% during the 2nd quarter. Grimes & Company Inc. now owns 62,014 shares of the company's stock worth $135,000 after buying an additional 27,243 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of iSpecimen by 166.3% during the 3rd quarter. Vanguard Group Inc. now owns 163,703 shares of the company's stock worth $270,000 after buying an additional 102,241 shares during the last quarter. Finally, BlackRock Inc. lifted its position in shares of iSpecimen by 903.6% during the 1st quarter. BlackRock Inc. now owns 71,175 shares of the company's stock worth $382,000 after buying an additional 64,083 shares during the last quarter. 11.61% of the stock is currently owned by institutional investors.
iSpecimen Company Profile
(Get Rating)
iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations.
Further Reading
- Get a free copy of the StockNews.com research report on iSpecimen (ISPC)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
Receive News & Ratings for iSpecimen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iSpecimen and related companies with MarketBeat.com's FREE daily email newsletter.
iSpecimen Inc. (NASDAQ:ISPC – Get Rating) was the recipient of a large increase in short interest in December. As of December 30th, there was short interest totalling 165,800 shares, an increase of 11.1% from the December 15th total of 149,300 shares. Based on an average daily trading volume, of 25,400 shares, the days-to-cover ratio is currently 6.5 days. Approximately 3.5% of the shares of the company are sold short.
iPasmle Inc.(纳斯达克股票代码:ISPC — Get Rating)是12月空头利率大幅增加的受益者。截至12月30日,空头利率共计165,800股,较12月15日的149,300股增长了11.1%。根据25,400股的平均每日交易量,目前天数与覆盖率为6.5天。该公司约有3.5%的股份被卖空。
iSpecimen Stock Performance
iPamble 股票表现
Shares of NASDAQ:ISPC remained flat at $1.63 during trading on Friday. The stock had a trading volume of 12,701 shares, compared to its average volume of 19,421. The business's 50 day moving average price is $1.47 and its 200 day moving average price is $1.84. The company has a debt-to-equity ratio of 0.12, a quick ratio of 8.55 and a current ratio of 8.55. iSpecimen has a 1 year low of $1.17 and a 1 year high of $5.70.
纳斯达克股票代码:ISPC的股价在周五的交易中持平至1.63美元。该股的交易量为12,701股,而平均交易量为19,421股。该公司的50天移动平均线价格为1.47美元,其200天移动平均线价格为1.84美元。该公司的债务与权益比率为0.12,速动比率为8.55,流动比率为8.55。iPamplem的1年低点为1.17美元,为1年来的最高水平5.70美元。
iSpecimen (NASDAQ:ISPC – Get Rating) last released its earnings results on Tuesday, November 8th. The company reported ($0.35) earnings per share for the quarter. iSpecimen had a negative net margin of 101.49% and a negative return on equity of 38.56%. The company had revenue of $2.58 million for the quarter.
iPasmle(纳斯达克股票代码:ISPC — Get Rating)上次发布财报是在11月8日星期二。该公司公布了本季度每股收益(0.35美元)。iSoplend的净利润率为负101.49%,股本回报率为负38.56%。该公司本季度的收入为258万美元。
Analysts Set New Price Targets
分析师设定了新的价格目标
Institutional Trading of iSpecimen
iSompline 的机构交易
Several institutional investors and hedge funds have recently modified their holdings of ISPC. Jane Street Group LLC bought a new stake in shares of iSpecimen during the 1st quarter worth $56,000. Grimes & Company Inc. lifted its position in shares of iSpecimen by 78.3% during the 2nd quarter. Grimes & Company Inc. now owns 62,014 shares of the company's stock worth $135,000 after buying an additional 27,243 shares during the last quarter. Vanguard Group Inc. lifted its position in shares of iSpecimen by 166.3% during the 3rd quarter. Vanguard Group Inc. now owns 163,703 shares of the company's stock worth $270,000 after buying an additional 102,241 shares during the last quarter. Finally, BlackRock Inc. lifted its position in shares of iSpecimen by 903.6% during the 1st quarter. BlackRock Inc. now owns 71,175 shares of the company's stock worth $382,000 after buying an additional 64,083 shares during the last quarter. 11.61% of the stock is currently owned by institutional investors.
一些机构投资者和对冲基金最近修改了其持有的ISPC。Jane Street Group LLC在第一季度购买了价值56,000美元的新股份。Grimes & Company Inc.在第二季度将其在iSamplem的股票头寸上调了78.3%。Grimes & Company Inc.在上个季度又购买了27,243股股票后,现在拥有该公司62,014股股票,价值13.5万美元。Vanguard Group Inc.在第三季度将其在iPasmell的股票头寸提高了166.3%。Vanguard Group Inc.在上个季度又购买了102,241股股票后,现在拥有该公司163,703股股票,价值27万美元。最后,贝莱德公司在第一季度将其在iPhonle的股票头寸提高了903.6%。贝莱德公司在上个季度又购买了64,083股股票后,现在拥有该公司71,175股股票,价值38.2万美元。该股票的11.61%目前由机构投资者持有。
iSpecimen Company Profile
iTampleme 公司简介
(Get Rating)
(获取评分)
iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations.
iPasmle Inc提供的技术将需要人类生物液、组织和活细胞进行研究的生命科学研究人员与全球医疗保健提供者组织中可用的生物标本联系起来。其基于云的技术使科学家能够在医院、实验室、生物库、血液中心和其他医疗保健组织网络中搜索标本和患者。
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on iSpecimen (ISPC)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
- 免费获取 StockNews.com 关于 iPamplem (ISPC) 的研究报告的副本
- MarketBeat Week 回顾 — 1/16 — 1/20
- Old Dominion 是否表明卡车运输正在刹车?
- 诺德斯特龙将对降价的恐惧带入零售业
- 埃克森美孚股票:距离买入点仅几步之遥
- 高股息收益的必和必拓认为中国将推动 “23” 的增长
Receive News & Ratings for iSpecimen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iSpecimen and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收 iSample 的新闻和评级 -在下面输入您的电子邮件地址,即可通过Marketbeat.com的免费每日电子邮件时事通讯接收iPample和相关公司的最新新闻和分析师评级的简明每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧